VCYT & NVT: Stocks Investors Should Keep On Their Radar

Veracyte (VCYT) is a leading provider for molecular tests for oncology. It recently announced better-than-expected 4Q and FY24 guidance. Nancy Prial discusses this stock and highlights it as one of her names to watch. She also looks at nVent (NVT) which focuses on products to help with building a more sustainable and electrified world. Some of nVent’s key areas of growth include modernizing the power grid, renewable energy, shift to E.V.’s, and data centers to power A.I. growth. Tune in to find out more about the stock market today.

Market On Close

09 Jan 2024

SHARE

Schwab Network's Newsletters

Daily insights for every investor